Literature DB >> 21667319

A rat model of neonatal candidiasis demonstrates the importance of lipases as virulence factors for Candida albicans and Candida parapsilosis.

David Trofa1, Lamia Soghier, Christina Long, Joshua D Nosanchuk, Attila Gacser, David L Goldman.   

Abstract

The host factors that contribute to the increased susceptibility of preterm neonates to invasive candidiasis have not been fully identified. In addition, there has been a lack of suitable models to study this problem. We show that rat pups, similar to premature neonates, display increased susceptibility to experimental Candida albicans infection. Further, we find that both C. albicans and Candida parapsilosis lipase disruptant mutants exhibit decreased virulence in rat pups, demonstrating the utility of the model to evaluate the impact of specific genes in disease pathogenesis. Our findings highlight the contribution of lipases to the virulence of C. albicans and C. parapsilosis and provide a new system to study the increased susceptibility of neonates to Candida infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667319     DOI: 10.1007/s11046-011-9429-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  36 in total

1.  Risk factors for candidemia in critically ill infants: a matched case-control study.

Authors:  Kristina N Feja; Fann Wu; Kevin Roberts; Maureen Loughrey; Mirjana Nesin; Elaine Larson; Phyllis Della-Latta; Janet Haas; Jeannie Cimiotti; Lisa Saiman
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

2.  Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers.

Authors:  A S Levin; S F Costa; N S Mussi; M Basso; S I Sinto; C Machado; D C Geiger; M C Villares; A Z Schreiber; A A Barone; M L Branchini
Journal:  Diagn Microbiol Infect Dis       Date:  1998-04       Impact factor: 2.803

3.  Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains.

Authors:  C Girmenia; P Martino; F De Bernardis; G Gentile; M Boccanera; M Monaco; G Antonucci; A Cassone
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci.

Authors:  M Toropainen; H Käyhty; L Saarinen; E Rosenqvist; E A Høiby; E Wedege; T Michaelsen; P H Mäkelä
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

5.  Risk factors for candidemia in a children's hospital.

Authors:  L MacDonald; C Baker; C Chenoweth
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

6.  Gastric acid secretion in preterm infants.

Authors:  E J Kelly; S J Newell; K G Brownlee; J N Primrose; P R Dear
Journal:  Early Hum Dev       Date:  1993-12-31       Impact factor: 2.079

7.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

8.  Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis.

Authors:  Kisha G Destin; Jennifer R Linden; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Early Hum Dev       Date:  2009-05-28       Impact factor: 2.079

9.  Reduced lymphocyte-mediated antifungal capacity in high-risk infants.

Authors:  Linda Witek-Janusek; Maliha J Shareef; Herbert L Mathews
Journal:  J Infect Dis       Date:  2002-05-24       Impact factor: 5.226

10.  Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations.

Authors:  A M Gillum; E Y Tsay; D R Kirsch
Journal:  Mol Gen Genet       Date:  1984
View more
  13 in total

Review 1.  The spectrum of fungi that infects humans.

Authors:  Julia R Köhler; Arturo Casadevall; John Perfect
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 2.  The Candida pathogenic species complex.

Authors:  Siobhán A Turner; Geraldine Butler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

Review 3.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

Review 4.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

5.  Galectin-3 plays an important role in protection against disseminated candidiasis.

Authors:  Jennifer R Linden; Monique E De Paepe; Sonia S Laforce-Nesbitt; Joseph M Bliss
Journal:  Med Mycol       Date:  2013-03-14       Impact factor: 4.076

6.  Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen Interface.

Authors:  Amanda B Arsenault; Joseph M Bliss
Journal:  Curr Fungal Infect Rep       Date:  2015-09-07

7.  Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infection.

Authors:  Alessia Bertini; Marina Zoppo; Lisa Lombardi; Cosmeri Rizzato; Elena De Carolis; Antonietta Vella; Riccardo Torelli; Maurizio Sanguinetti; Arianna Tavanti
Journal:  Virulence       Date:  2015-12-02       Impact factor: 5.882

8.  Human endothelial cells internalize Candida parapsilosis via N-WASP-mediated endocytosis.

Authors:  Tatsushi Shintaku; Kyle A Glass; Matthew P Hirakawa; Sarah J Longley; Richard J Bennett; Joseph M Bliss; Sunil K Shaw
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

9.  Secreted Candida parapsilosis lipase modulates the immune response of primary human macrophages.

Authors:  Adél Tóth; Tibor Németh; Katalin Csonka; Péter Horváth; Csaba Vágvölgyi; Csaba Vizler; Joshua D Nosanchuk; Attila Gácser
Journal:  Virulence       Date:  2014-03-13       Impact factor: 5.882

10.  Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response.

Authors:  Renáta Tóth; Maria F Alonso; Judith M Bain; Csaba Vágvölgyi; Lars-Peter Erwig; Attila Gácser
Journal:  Front Microbiol       Date:  2015-10-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.